Showing results (21-30 of 81) with videos related to

Sort By:
Pageof 9
The Proceedings of the Nutrition Society|June 24, 2010
The importance of fatty liver disease in clinical practiceJeremy F L Cobbold, Quentin M Anstee, Simon D Taylor-Robinson
Metabolism: Clinical and Experimental|February 1, 1995
Serum sialic acid as an indicator of change in coronary artery diseaseG F Watts, M A Crook, S Haq, et al.
Transfusion Medicine (Oxford, England)|September 1, 1994
Electrokinetic properties of human cryopreserved plateletsE A Bateson, M A Crook, B Brozovic, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 15, 1993
Serum sialic acid and acute phase proteins in type 1 and type 2 diabetes mellitusM A Crook, P Tutt, H Simpson, et al.
The American Journal of Cardiology|September 29, 2000
High-density lipoprotein cholesterol and triglyceride response with simvastatin versus atorvastatin in familial hypercholesterolemiaA S Wierzbicki, P J Lumb, G Chik, et al.
Diabetes Research and Clinical Practice|February 12, 2000
No difference in serum sialic acid in type 2 diabetic patients from the United Arab Emirates with and without diabetic retinopathyM A Crook, S Khandhadia, P Lumb, et al.
Atherosclerosis|September 17, 1999
Plasma sialic acid and coronary artery atheromatous load in patients with stable chest painE B Wu, P Lumb, J B Chambers, et al.
QJM : Monthly Journal of the Association of Physicians|January 24, 1998
Fenofibrate plus simvastatin therapy versus simvastatin plus cholestyramine therapy for familial hypercholesterolaemiaA S Wierzbicki, P J Lumb, J Cheung, et al.
The American Journal of Cardiology|February 13, 2001
Fibrinogen response with simvastatin versus atorvastatin in familial hypercholesterolemiaA S Wierzbicki, P J Lumb, G Chik, et al.
International Journal of Clinical Practice|February 29, 2000
Comparison of therapy with simvastatin 80 mg and atorvastatin 80 mg in patients with familial hypercholesterolaemiaA S Wierzbicki, P J Lumb, G Chik, et al.
Pageof 9